How many insider trades does FilingIQ track for XOMA?

FilingIQ tracks 417 Form 4 insider transactions for XOMA (XOMA Royalty Corp), covering filings from Jan 15, 2015 onwards. 24 of those were filed in the last 90 days.

Are XOMA insiders net buyers or net sellers?

Across the full Form 4 history for XOMA, 109 transactions (26%) were open-market purchases and 103 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does XOMA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is XOMA in?

XOMA Royalty Corp (XOMA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $313.54M.

XOMA insider trading

NasdaqGM Healthcare

XOMA Royalty Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

417

Last 90 days

Buys / sells

26% / 25%

Market cap

$313.54M

About XOMA Royalty Corp

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Company website: www.xoma.com

XOMA insider activity at a glance

FilingIQ has scored 417 insider transactions for XOMA since Jan 15, 2015. The most recent filing in our index is dated Apr 20, 2026.

Across the full history, 109 open-market purchases and 103 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on XOMA insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live XOMA trades on FilingIQ Raw filings on SEC EDGAR

Latest XOMA Form 4 filings

Hughes Owen Chief Executive Officer

S May 20, 2025

Hughes Owen Chief Executive Officer

S Nov 13, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding XOMA

Opaleye Management Inc.

$7.78M · 1.0% of AUM

Frequently asked

How many insider trades does FilingIQ track for XOMA?: FilingIQ tracks 417 Form 4 insider transactions for XOMA (XOMA Royalty Corp), covering filings from Jan 15, 2015 onwards. 24 of those were filed in the last 90 days.
Are XOMA insiders net buyers or net sellers?: Across the full Form 4 history for XOMA, 109 transactions (26%) were open-market purchases and 103 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does XOMA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is XOMA in?: XOMA Royalty Corp (XOMA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $313.54M.

Methodology & sources

Every XOMA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.